April 27, 2017 - La Jolla Pharmaceutical Co. (NASDAQ:LJPC) has filed a financial statement reporting Liabilities of $9,758,000 USD. Previously, on May 10, 2018, La Jolla Pharmaceutical Co. reported Liabilities of $29,488,000 USD. This represents a change of -66.91% in Liabilities.
Related News Stories
Biotech stocks represent a peculiar conundrum. On one hand, they are scientifically the most exciting investment sector. Successes here could spark revolutionary therapies that could end or at least alleviate human suffering. But the industry is heavily marked with failures and agonizing disappointments. (7-1)
Today we will discuss Abeona Therapeutics (ABEO) after the company announced that it has nabbed a Rare Pediatric Disease designation from the FDA for ABO-202 for the treatment of CLN1 disease, which is a rare inherited disorder of the nervous system. (159-4)